CompletedNot Applicable

Hyperlactatemia During and After Tumorcraniotomy

Denmark450 participantsStarted 2020-07-28

Plain-language summary

This study aims to investigate the association between hyperlactatemia and neurological disability, length-of-stay and mortality in patients who undergo tumorcraniotomy. The risk factors that induce lactat accumulation will also be explored.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>/= 18 years * Must undergo elective tumor craniotomy * Understand oral and written Danish Exclusion Criteria: * Adults with incapacity * Stereotactic biopsy * Lack of informed and signed consent to participate in study

What they're measuring

Neurological disability

Timeframe: Change from baseline mRS at 30 days after surgery

Trial details

NCT IDNCT04410315

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-18

View on ClinicalTrials.gov More Hyperlactatemia trials